|
Akums Drugs & Pharmaceuticals Ltd.
|
Income Statement
|
|
|
You can view the
Income Statement
for the last 5 years.
|
Market Cap. (Rs.)
|
6610.55 Cr.
|
P/BV
|
2.17
|
Book Value (Rs.)
|
193.65
|
|
52 Week High/Low (Rs.)
|
678/405
|
FV/ML
|
2/1
|
P/E(X)
|
19.55
|
|
Bookclosure
|
|
EPS (Rs.)
|
21.49
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR |
| FaceValue | 2.00 | 2.00 | 2.00 | 2.00 |
| | | | | |
| | | | | |
| INCOME | | | | |
| Revenue From Operations [Net] | 4013.88 | 3971.21 | 3442.21 | 3581.60 |
| Other Operating Revenues | 104.28 | 206.98 | 212.61 | 90.30 |
| Total Operating Revenues | 4118.16 | 4178.18 | 3654.82 | 3671.89 |
| | | | | |
| Other Income | 52.12 | 34.03 | 46.11 | 22.63 |
| Total Revenue | 4170.28 | 4212.21 | 3700.93 | 3694.52 |
| | | | | |
| EXPENSES | | | | |
| Cost Of Materials Consumed | 2253.61 | 2278.37 | 2028.09 | 2038.59 |
| Purchase Of Stock-In Trade | 181.47 | 259.53 | 221.79 | 394.21 |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -1.65 | 12.34 | 24.04 | -87.74 |
| Employee Benefit Expenses | 715.82 | 646.86 | 590.13 | 507.76 |
| Finance Costs | 34.60 | 50.61 | 46.25 | 16.66 |
| Depreciation And Amortisation Expenses | 153.45 | 125.64 | 112.81 | 94.68 |
| Other Expenses | 504.42 | 858.10 | 452.83 | 910.80 |
| Total Expenses | 3841.72 | 4231.45 | 3475.93 | 3874.95 |
| | | | | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 328.56 | -19.24 | 225.00 | -180.42 |
| | | | | |
| Exceptional Items | 16.70 | -26.03 | -74.50 | -12.98 |
| Profit/Loss Before Tax | 345.25 | -45.28 | 150.50 | -193.40 |
| | | | | |
| Tax Expenses-Continued Operations | | | | |
| Current Tax | 81.37 | 74.03 | 78.13 | 69.05 |
| Deferred Tax | -79.43 | -103.32 | -27.26 | -6.04 |
| Tax For Earlier Years | -0.46 | -16.77 | 1.61 | -5.33 |
| Total Tax Expenses | 1.48 | -46.07 | 52.48 | 57.68 |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 343.78 | 0.79 | 98.02 | -251.08 |
| | | | | |
| Profit/Loss From Continuing Operations | 343.78 | 0.79 | 98.02 | -251.08 |
| | | | | |
| Profit/Loss For The Period | 343.78 | 0.79 | 98.02 | -251.08 |
| | | | | |
| Minority Interest | -5.60 | -4.83 | -2.96 | -1.66 |
| Share Of Profit/Loss Of Associates | 0.00 | 0.00 | -0.20 | 0.20 |
| Consolidated Profit/Loss After MI And Associates | 338.18 | -4.04 | 94.86 | -252.54 |
| | | | | |
| OTHER INFORMATION | | | | |
| | | | | |
| EARNINGS PER SHARE | | | | |
| Basic EPS (Rs.) | 22.60 | -0.28 | 6.63 | -17.65 |
| Diluted EPS (Rs.) | 22.60 | -0.28 | 6.63 | -17.65 |
